topic_id,query,question,narrative,covid,lexi_query,metamap_00_term_query,metamap_00_id_query,metamap_01_term_query,metamap_01_id_query,metamap_10_term_query,metamap_10_id_query,metamap_11_term_query,metamap_11_id_query,lexi_question,metamap_00_term_question,metamap_00_id_question,metamap_01_term_question,metamap_01_id_question,metamap_10_term_question,metamap_10_id_question,metamap_11_term_question,metamap_11_id_question,lexi_narrative,metamap_00_term_narrative,metamap_00_id_narrative,metamap_01_term_narrative,metamap_01_id_narrative,metamap_10_term_narrative,metamap_10_id_narrative,metamap_11_term_narrative,metamap_11_id_narrative,lexi_covid,metamap_00_term_covid,metamap_00_id_covid,metamap_01_term_covid,metamap_01_id_covid,metamap_10_term_covid,metamap_10_id_covid,metamap_11_term_covid,metamap_11_id_covid
1,coronavirus origin,origin covid-19,seek range information sars-cov-2 virus's origin include evolution animal source first transmission human,covid-19,,National origin Genus: Coronavirus Beginning Participation Type - origin,C0079946 C0206419 C0439659 C1550512,,,Genus: Coronavirus Beginning,C0206419 C0439659,,,,National origin Beginning Participation Type - origin COVID-19,C0079946 C0439659 C1550512 C5203670,,,National origin COVID-19,C0079946 C5203670,,,,Animals Biological Evolution disease transmission qualifier Virus National origin Homo sapiens First (number) disease transmission AS virus Including (qualifier) Beginning Source control act - information Firstly Range transmission process Information Participation Type - origin include - SetOperator Error severity - Information Acknowledgement Detail Type - Information Term Source Sample Range Include (action) Concept model range (foundation metadata concept) Source (property) (qualifier value) Analytical Procedure Range SARS-CoV-2,C0003062 C0015219 C0040722 C0042776 C0079946 C0086418 C0205435 C0242781 C0319157 C0332257 C0439659 C0449416 C0870705 C1279901 C1514721 C1521797 C1533716 C1550512 C1552866 C1561527 C1561528 C1705919 C2348147 C2700399 C3542016 C4521696 C4760793 C5203676,Biological Evolution Homo sapiens,C0015219 C0086418,Animals Biological Evolution Homo sapiens First (number) disease transmission AS virus Beginning Source Acknowledgement Detail Type - Information Include (action) Analytical Procedure Range SARS-CoV-2,C0003062 C0015219 C0086418 C0205435 C0242781 C0319157 C0439659 C0449416 C1561528 C2700399 C4760793 C5203676,Biological Evolution Homo sapiens,C0015219 C0086418,,COVID-19,C5203670,,,COVID-19,C5203670,,
2,coronavirus response weather change,coronavirus respond change weather,seek range information sars-cov-2 virus viability different weather climate condition well information relate transmission virus different climate condition,covid-19,,Weather Genus: Coronavirus Changing Changed status Response process Disease Response Delta (difference) Response (statement) Response (communication) Change -- procedure,C0043085 C0206419 C0392747 C0443172 C0871261 C1704632 C1705241 C1706817 C2911692 C4319952,Weather,C0043085,Weather Genus: Coronavirus Disease Response Change -- procedure,C0043085 C0206419 C1704632 C4319952,Weather,C0043085,,Weather Genus: Coronavirus Changing Changed status Delta (difference) Change -- procedure,C0043085 C0206419 C0392747 C0443172 C1705241 C4319952,Weather,C0043085,Weather Genus: Coronavirus Change -- procedure,C0043085 C0206419 C4319952,Weather,C0043085,  ,Climate Disease Weather Condition control act - information Range Information Error severity - Information Acknowledgement Detail Type - Information Virus Viability Different Logical Condition Sample Range Concept model range (foundation metadata concept) Condition:Find:Pt:^Patient:Nom Condition Domain Analytical Procedure Range SARS-CoV-2,C0008946 C0012634 C0043085 C0348080 C0870705 C1514721 C1533716 C1561527 C1561528 C1563773 C1705242 C1705253 C2348147 C3542016 C3864998 C4722256 C4760793 C5203676,Climate Disease Weather Virus Viability,C0008946 C0012634 C0043085 C1563773,Climate Disease Weather Acknowledgement Detail Type - Information Virus Viability Different Analytical Procedure Range SARS-CoV-2,C0008946 C0012634 C0043085 C1561528 C1563773 C1705242 C4760793 C5203676,Climate Disease Weather Virus Viability,C0008946 C0012634 C0043085 C1563773,,COVID-19,C5203670,,,COVID-19,C5203670,,
3,coronavirus immunity,sars-cov2 infected people develop immunity cross protection possible,seek study immunity develop due infection sars-cov2 cross protection gain due infection coronavirus type,covid-19,,Immunity Genus: Coronavirus,C0020964 C0206419,,,Immunity Genus: Coronavirus,C0020964 C0206419,,,  ,Immunity Persons Possible Infected Severe Acute Respiratory Syndrome SARS coronavirus SARS gene SARS2 gene Possibly Related to Intervention Possible diagnosis Cross Protection,C0020964 C0027361 C0332149 C0439663 C1175175 C1175743 C1419818 C1425041 C1705910 C2362652 C2717886,Severe Acute Respiratory Syndrome SARS coronavirus Cross Protection,C1175175 C1175743 C2717886,Immunity Persons Possible Infected Severe Acute Respiratory Syndrome Cross Protection,C0020964 C0027361 C0332149 C0439663 C1175175 C2717886,Severe Acute Respiratory Syndrome Cross Protection,C1175175 C2717886,     ,Clinical Research Communicable Diseases Immunity Genus: Coronavirus Type - attribute Room of building - Study Due to Scientific Study Severe Acute Respiratory Syndrome SARS coronavirus SARS gene SGCG gene SARS2 gene Gain Type - ParameterizedDataType Adverse Event Associated with Infection Study Object DICOM Study Study Cross Protection Due Infection GDC Type Terminology,C0008972 C0009450 C0020964 C0206419 C0332307 C0557651 C0678226 C0947630 C1175175 C1175743 C1419818 C1420009 C1425041 C1517378 C1552651 C1556682 C1705923 C1880229 C2603343 C2717886 C3146286 C3714514 C5202910,Communicable Diseases Severe Acute Respiratory Syndrome SARS coronavirus Cross Protection,C0009450 C1175175 C1175743 C2717886,Clinical Research Communicable Diseases Immunity Genus: Coronavirus Severe Acute Respiratory Syndrome Gain Cross Protection Due GDC Type Terminology,C0008972 C0009450 C0020964 C0206419 C1175175 C1517378 C2717886 C3146286 C5202910,Communicable Diseases Severe Acute Respiratory Syndrome Cross Protection,C0009450 C1175175 C2717886,,COVID-19,C5203670,,,COVID-19,C5203670,,
4,people die coronavirus,cause death covid-19,study look mechanism death covid-19,covid-19,,Structure of diencephalon Persons Genus: Coronavirus,C0012144 C0027361 C0206419,,,Structure of diencephalon Persons Genus: Coronavirus,C0012144 C0027361 C0206419,,,,Cessation of life Etiology aspects Death (finding) Science of Etiology Event Consequence - Death Adverse Event Associated with Death Death Domain COVID-19,C0011065 C0015127 C1306577 C1524003 C1546949 C1559081 C4722467 C5203670,Death Domain,C4722467,Etiology aspects Death Domain COVID-19,C0015127 C4722467 C5203670,Death Domain,C4722467,,Clinical Research Cessation of life Personal appearance Mechanism (attribute) Room of building - Study Scientific Study Death (finding) Event Consequence - Death Adverse Event Associated with Death Study Object Mechanism Component of Device DICOM Study Study Death Domain COVID-19,C0008972 C0011065 C0233426 C0441712 C0557651 C0947630 C1306577 C1546949 C1559081 C1705923 C1706376 C1880229 C2603343 C4722467 C5203670,Death Domain,C4722467,Clinical Research Personal appearance Mechanism (attribute) Death Domain COVID-19,C0008972 C0233426 C0441712 C4722467 C5203670,Death Domain,C4722467,,COVID-19,C5203670,,,COVID-19,C5203670,,
5,animal model covid-19,drug active sars-cov sars-cov-2 animal study,paper describe result test drug bind spike protein virus drug animal model paper sars-cov-2 infection cell culture assay also relevant,covid-19,,Animal Disease Models Animal Model COVID-19,C0012644 C0599779 C5203670,Animal Disease Models,C0012644,Animal Disease Models COVID-19,C0012644 C5203670,Animal Disease Models,C0012644,    ,Pharmaceutical Preparations Active Active State Animal Study Active brand of pseudoephedrine-triprolidine SARS coronavirus Pharmacologic Substance Concept Status - Active EditStatus - Active Managed Participation Status - active Role Status - active Entity Status - active Document Storage - active Document Storage Status - Active Immunization Registry Status - Active Active Control Active Study active (HL7 RoleLink) Active License SARS-CoV-2,C0013227 C0205177 C0679217 C0683949 C0718247 C1175743 C1254351 C1553875 C1561507 C1561508 C1561509 C1561510 C1561511 C1561512 C1561513 C1706449 C2347179 C3853793 C3888249 C5203676,SARS coronavirus,C1175743,Pharmaceutical Preparations Active Animal Study SARS coronavirus SARS-CoV-2,C0013227 C0205177 C0683949 C1175743 C5203676,SARS coronavirus,C1175743,         ,"Biological Assay Cell Culture Techniques Communicable Diseases Animal Disease Models Pharmaceutical Preparations Paper Substance Abuse Detection Viral Proteins assay qualifier Animal Model M Protein, multiple myeloma Binding action Binding (Molecular Function) Pharmacologic Substance Result Assay What subject filter - Result Paper Authorization Adverse Event Associated with Infection Relevance Experimental Result Paper Dosing Unit Infection Cell Culture SARS-CoV-2",C0005507 C0007585 C0009450 C0012644 C0013227 C0030351 C0038577 C0042736 C0243073 C0599779 C0700271 C1145667 C1167622 C1254351 C1274040 C1510438 C1546471 C1547566 C1556682 C2347946 C2825142 C2826224 C3714514 C4721550 C5203676,"Cell Culture Techniques Communicable Diseases Animal Disease Models Paper Substance Abuse Detection Viral Proteins M Protein, multiple myeloma Assay Cell Culture",C0007585 C0009450 C0012644 C0030351 C0038577 C0042736 C0700271 C1510438 C4721550,"Communicable Diseases Animal Disease Models Pharmaceutical Preparations Paper Substance Abuse Detection Viral Proteins M Protein, multiple myeloma Binding (Molecular Function) Assay Relevance Experimental Result Cell Culture SARS-CoV-2",C0009450 C0012644 C0013227 C0030351 C0038577 C0042736 C0700271 C1167622 C1510438 C2347946 C2825142 C4721550 C5203676,"Communicable Diseases Animal Disease Models Paper Substance Abuse Detection Viral Proteins M Protein, multiple myeloma Assay Cell Culture",C0009450 C0012644 C0030351 C0038577 C0042736 C0700271 C1510438 C4721550,,COVID-19,C5203670,,,COVID-19,C5203670,,
6,coronavirus test rapid test,type rapid test covid-19 develop,look study identify way diagnose covid-19 rapidly,covid-19,   ,Laboratory Procedures Testing Genus: Coronavirus Tests (qualifier value) Test Result Test Dosing Unit Test Name Blood Products Laboratory Testing Test - temporal region,C0022885 C0039593 C0206419 C0392366 C0456984 C1704435 C2826273 C3831328 C4318744,,,Genus: Coronavirus Blood Products Laboratory Testing,C0206419 C3831328,,, ,Laboratory Procedures Testing Type - attribute Tests (qualifier value) Rapid Test Result SGCG gene Type - ParameterizedDataType Test Dosing Unit Test Name Blood Products Laboratory Testing Test - temporal region GDC Type Terminology COVID-19,C0022885 C0039593 C0332307 C0392366 C0456962 C0456984 C1420009 C1552651 C1704435 C2826273 C3831328 C4318744 C5202910 C5203670,,,Rapid Blood Products Laboratory Testing GDC Type Terminology COVID-19,C0456962 C3831328 C5202910 C5203670,,,,Clinical Research Diagnosis Personal appearance Rapid Room of building - Study Scientific Study Study Object DICOM Study Study COVID-19,C0008972 C0011900 C0233426 C0456962 C0557651 C0947630 C1705923 C1880229 C2603343 C5203670,,,Clinical Research Diagnosis Personal appearance Rapid COVID-19,C0008972 C0011900 C0233426 C0456962 C5203670,,,,COVID-19,C5203670,,,COVID-19,C5203670,,
7,serological test coronavirus,serological test detect antibody coronavirus,look assay measure immune response covid-19 help determine past infection subsequent possible immunity,covid-19, ,Serologic tests Genus: Coronavirus,C0036743 C0206419,Serologic tests,C0036743,Serologic tests Genus: Coronavirus,C0036743 C0206419,Serologic tests,C0036743,,"Antibodies Immunoglobulins Serologic tests Genus: Coronavirus Detected (finding) immunoglobulin complex location antibody activity Immunoglobulin complex location, circulating Dosing Days to Detection",C0003241 C0021027 C0036743 C0206419 C0442726 C1167408 C1621287 C3665580 C3891454,Antibodies Immunoglobulins Serologic tests,C0003241 C0021027 C0036743,Antibodies Serologic tests Genus: Coronavirus Detected (finding),C0003241 C0036743 C0206419 C0442726,Antibodies Serologic tests,C0003241 C0036743, ,Biological Assay Immunity Measures Personal appearance Measurement assay qualifier Immune response Possible Following Determined by Assisted (qualifier value) Assay Help document Possibly Related to Intervention Possible diagnosis Past infection COVID-19,C0005507 C0020964 C0079809 C0233426 C0242485 C0243073 C0301872 C0332149 C0332282 C0521095 C1269765 C1510438 C1552861 C1705910 C2362652 C4699566 C5203670,Measures Assay,C0079809 C1510438,Immunity Measures Personal appearance Immune response Possible Following Determined by Assisted (qualifier value) Assay Past infection COVID-19,C0020964 C0079809 C0233426 C0301872 C0332149 C0332282 C0521095 C1269765 C1510438 C4699566 C5203670,Measures Assay,C0079809 C1510438,,COVID-19,C5203670,,,COVID-19,C5203670,,
8,coronavirus report,lack test availability lead underreporting true incidence covid-19,look study answer question impact lack complete test covid-19 incidence prevalence covid-19,covid-19,,Genus: Coronavirus Report (document) Reporting Regulatory Report Report:Finding:Point in time:{Setting}:Document:{Role},C0206419 C0684224 C0700287 C3273238 C4255046,,,Genus: Coronavirus Regulatory Report,C0206419 C3273238,,,,"Incidence Laboratory Procedures lead Testing Leads (device) True incidence of cases Lacking Tests (qualifier value) Test Result Availability of Lead measurement Plumbum metallicum, homeopathic preparation Leading Test Dosing Unit Dietary Lead Test Name Cardiac Lead Procedure Blood Products Laboratory Testing Test - temporal region COVID-19",C0021149 C0022885 C0023175 C0039593 C0181586 C0205238 C0220856 C0332268 C0392366 C0456984 C0470187 C0524167 C1442948 C1522538 C1704435 C2348269 C2826273 C3275067 C3831328 C4318744 C5203670,Incidence lead,C0021149 C0023175,Incidence lead True Lacking Availability of Blood Products Laboratory Testing COVID-19,C0021149 C0023175 C0205238 C0332268 C0470187 C3831328 C5203670,Incidence lead,C0021149 C0023175, ,Clinical Research Laboratory Procedures Testing Complete Personal appearance Lacking Tests (qualifier value) Test Result Room of building - Study Scientific Study Question (inquiry) Completion Status for valid values - Complete Test Dosing Unit Study Object Finish - dosing instruction imperative Response (statement) IMPACT gene DICOM Study Study Test Name Blood Products Laboratory Testing Data operation - complete Impact Complete Pharyngeal Contraction Test - temporal region COVID-19,C0008972 C0022885 C0039593 C0205197 C0233426 C0332268 C0392366 C0456984 C0557651 C0947630 C1522634 C1548561 C1704435 C1705923 C1706059 C1706817 C1825598 C1880229 C2603343 C2826273 C3831328 C3853530 C4049986 C4283785 C4318744 C5203670,,,Clinical Research Complete Personal appearance Lacking Question (inquiry) Response (statement) IMPACT gene Blood Products Laboratory Testing COVID-19,C0008972 C0205197 C0233426 C0332268 C1522634 C1706817 C1825598 C3831328 C5203670,,,,COVID-19,C5203670,,,COVID-19,C5203670,,
9,coronavirus canada,covid-19 affect canada,seek data relate infection confirm suspect project health outcome symptoms hospitalization intensive care mortality,covid-19,,Canada Genus: Coronavirus,C0006823 C0206419,Canada,C0006823,Canada Genus: Coronavirus,C0006823 C0206419,Canada,C0006823,,Affect (mental function) Canada COVID-19,C0001721 C0006823 C5203670,Canada,C0006823,Affect (mental function) Canada COVID-19,C0001721 C0006823 C5203670,Canada,C0006823,  ,Communicable Diseases Health Hospitalization Mortality Vital Statistics Aspects of mortality statistics intensive care Relate - vinyl resin Confirmed by Symptoms aspect Confirmation Suspected qualifier Result Confirm Symptoms Data Specialty Type - Intensive care Adverse Event Associated with Infection Allergy Clinical Status - Suspect Project Data call receiving device Infection Data (eukaryote),C0009450 C0018684 C0019993 C0026565 C0026566 C0085559 C0163712 C0521093 C0683368 C0750484 C0750491 C1274040 C1456348 C1457887 C1511726 C1548354 C1556682 C1571873 C1709701 C3245479 C3714514 C3714741,Communicable Diseases Hospitalization intensive care Symptoms,C0009450 C0019993 C0085559 C1457887,Communicable Diseases Health Hospitalization Aspects of mortality statistics intensive care Relate - vinyl resin Suspected qualifier Result Confirm Symptoms Data Project,C0009450 C0018684 C0019993 C0026566 C0085559 C0163712 C0750491 C1274040 C1456348 C1457887 C1511726 C1709701,Communicable Diseases Hospitalization intensive care Symptoms,C0009450 C0019993 C0085559 C1457887,,COVID-19,C5203670,,,COVID-19,C5203670,,
10,coronavirus social distancing impact,social distancing impact slow spread covid-19,seek specific information study measure covid-19's transmission one social distancing non-social distancing approach,covid-19,,Genus: Coronavirus Social IMPACT gene Impact,C0206419 C0728831 C1825598 C4049986,,,Genus: Coronavirus Social IMPACT gene,C0206419 C0728831 C1825598,,,,Spreading (qualifier value) Slow Social IMPACT gene Smear - instruction imperative Impact COVID-19,C0332261 C0439834 C0728831 C1825598 C1947932 C4049986 C5203670,,,Slow Social IMPACT gene Smear - instruction imperative COVID-19,C0439834 C0728831 C1825598 C1947932 C5203670,,,,Clinical Research disease transmission qualifier Measures Specific qualifier value One Measurement disease transmission Approach Room of building - Study Social control act - information Scientific Study NON Mouse Negation transmission process Information Entity Determiner - specific Error severity - Information Acknowledgement Detail Type - Information Study Object DICOM Study Study 1 (finding) COVID-19,C0008972 C0040722 C0079809 C0205369 C0205447 C0242485 C0242781 C0449445 C0557651 C0728831 C0870705 C0947630 C1513853 C1518422 C1521797 C1533716 C1552740 C1561527 C1561528 C1705923 C1880229 C2603343 C5201140 C5203670,Measures,C0079809,Clinical Research Measures disease transmission Approach Social NON Mouse Entity Determiner - specific Acknowledgement Detail Type - Information 1 (finding) COVID-19,C0008972 C0079809 C0242781 C0449445 C0728831 C1513853 C1552740 C1561528 C5201140 C5203670,Measures,C0079809,,COVID-19,C5203670,,,COVID-19,C5203670,,
11,coronavirus hospital rationing,guideline triaging patient infect coronavirus,seek information guideline prioritize covid-19 patient infect coronavirus base demographic clinical sign serology test,covid-19, Hospital,Hospitals Genus: Coronavirus Hospital environment Organization unit type - Hospital,C0019994 C0206419 C1510665 C1547192,Hospitals,C0019994,Hospitals Genus: Coronavirus,C0019994 C0206419,Hospitals,C0019994,,Patients Guidelines Coronavirus Infections Guideline [Publication Type] Specimen Type - Patient Mail Claim Party - Patient Report source - Patient Relationship modifier - Patient Specimen Source Codes - Patient Disabled Person Code - Patient Veterinary Patient,C0030705 C0162791 C0206750 C0282423 C1550655 C1578481 C1578483 C1578484 C1578485 C1578486 C1705908,Guidelines Coronavirus Infections,C0162791 C0206750,Patients Guidelines Coronavirus Infections,C0030705 C0162791 C0206750,Guidelines Coronavirus Infections,C0162791 C0206750, Alkali  ,Alkalies Demography Patients Serologic tests Guidelines Base Clinical Coronavirus Infections Structure of base of prostate Guideline [Publication Type] Physical findings control act - information Information Language Ability - Sign Base - RX Component Type base - RoleClass Specimen Type - Patient Error severity - Information Acknowledgement Detail Type - Information Mail Claim Party - Patient Report source - Patient Relationship modifier - Patient Specimen Source Codes - Patient Disabled Person Code - Patient Unit dose - Base nitrogenous base Veterinary Patient Base - General Qualifier BPIFA4P gene Dental Base Anatomical base Clinical Lot Clinical Batch COVID-19,C0002055 C0011298 C0030705 C0036743 C0162791 C0178499 C0205210 C0206750 C0227958 C0282423 C0311392 C0870705 C1533716 C1547188 C1549548 C1550601 C1550655 C1561527 C1561528 C1578481 C1578483 C1578484 C1578485 C1578486 C1626935 C1704464 C1705908 C1705938 C1843354 C1880279 C2987514 C3272565 C4523057 C5203670,Demography Serologic tests Guidelines Coronavirus Infections,C0011298 C0036743 C0162791 C0206750,Alkalies Demography Patients Serologic tests Guidelines Clinical Coronavirus Infections Language Ability - Sign Acknowledgement Detail Type - Information COVID-19,C0002055 C0011298 C0030705 C0036743 C0162791 C0205210 C0206750 C1547188 C1561528 C5203670,Demography Serologic tests Guidelines Coronavirus Infections,C0011298 C0036743 C0162791 C0206750,,COVID-19,C5203670,,,COVID-19,C5203670,,
12,coronavirus quarantine,best practice hospital home maintain quarantine,seek information best practice activity duration quarantine expose infect covid-19 virus,covid-19, Quarantine,Quarantine Genus: Coronavirus,C0034386 C0206419,Quarantine,C0034386,Quarantine Genus: Coronavirus,C0034386 C0206419,Quarantine,C0034386, Hospital  Quarantine,Hospitals Maintenance Quarantine Home environment Hospital environment Organization unit type - Hospital Organization unit type - Home Visit User Code - Home Person location type - Home Address type - Home home health encounter Best Practices,C0019994 C0024501 C0034386 C0442519 C1510665 C1547192 C1547197 C1548341 C1548530 C1549632 C1553498 C3179154,Hospitals Quarantine Best Practices,C0019994 C0034386 C3179154,Hospitals Maintenance Quarantine Address type - Home Best Practices,C0019994 C0024501 C0034386 C1549632 C3179154,Hospitals Quarantine Best Practices,C0019994 C0034386 C3179154,    Quarantine ,Physical activity Quarantine Virus Active AS virus Infected Activities Duration (temporal concept) Duration brand of oxymetazoline control act - information Information Error severity - Information Acknowledgement Detail Type - Information Duration Best Practices Activity (animal life circumstance) Infection Physical Activity Measurement FDA Establishment Activity Terminology COVID-19,C0026606 C0034386 C0042776 C0205177 C0319157 C0439663 C0441655 C0449238 C0720099 C0870705 C1533716 C1561527 C1561528 C2926735 C3179154 C3668946 C3714514 C4049938 C4049939 C5203670,Physical activity Quarantine Best Practices,C0026606 C0034386 C3179154,Physical activity Quarantine AS virus Infected Acknowledgement Detail Type - Information Duration Best Practices COVID-19,C0026606 C0034386 C0319157 C0439663 C1561528 C2926735 C3179154 C5203670,Physical activity Quarantine Best Practices,C0026606 C0034386 C3179154,,COVID-19,C5203670,,,COVID-19,C5203670,,
13,coronavirus spread,transmission route coronavirus,look information possible way contract covid-19 people animal object,covid-19,,Genus: Coronavirus Spreading (qualifier value) Smear - instruction imperative,C0206419 C0332261 C1947932,,,Genus: Coronavirus Smear - instruction imperative,C0206419 C1947932,,,,Drug Administration Routes disease transmission qualifier Genus: Coronavirus disease transmission Route transmission process CDISC SDTM Route of Administration Terminology,C0013153 C0040722 C0206419 C0242781 C0449444 C1521797 C1879941,Drug Administration Routes,C0013153,Drug Administration Routes disease transmission qualifier Genus: Coronavirus,C0013153 C0040722 C0206419,Drug Administration Routes,C0013153,,Animals Persons Personal appearance Possible Contract agreement Physical object control act - information Object Class Information Transaction counts and value totals - contract Error severity - Information Acknowledgement Detail Type - Information Computer Programming Object Routine Contract Possibly Related to Intervention Possible diagnosis COVID-19,C0003062 C0027361 C0233426 C0332149 C0332522 C0347997 C0870705 C1518526 C1533716 C1548281 C1561527 C1561528 C1704861 C1705564 C1705910 C2362652 C5203670,,,Animals Persons Personal appearance Possible Contract agreement Acknowledgement Detail Type - Information Computer Programming Object COVID-19,C0003062 C0027361 C0233426 C0332149 C0332522 C1561528 C1704861 C5203670,,,,COVID-19,C5203670,,,COVID-19,C5203670,,
14,coronavirus super spreader,evidence relate covid-19 super spreader,seek range information relate number proportion super spreader pattern behavior lead spread potential prevention strategy target specifically toward super spreader,covid-19, Spreader,Spreader Genus: Coronavirus,C0183479 C0206419,,,Spreader Genus: Coronavirus,C0183479 C0206419,,, Spreader,Relate - vinyl resin Spreader Evidence COVID-19,C0163712 C0183479 C3887511 C5203670,,,Relate - vinyl resin Spreader Evidence COVID-19,C0163712 C0183479 C3887511 C5203670,,, Number  Spreader  Habits    Spreader,Relate - vinyl resin Spreader Numbers Count of entities control act - information Range Information MDF AttributeType - Number Error severity - Information Acknowledgement Detail Type - Information Proportion Sample Range Concept model range (foundation metadata concept) Analytical Procedure Range,C0163712 C0183479 C0237753 C0449788 C0870705 C1514721 C1533716 C1554106 C1561527 C1561528 C1709707 C2348147 C3542016 C4760793,,,Relate - vinyl resin Spreader Count of entities Acknowledgement Detail Type - Information Proportion Analytical Procedure Range,C0163712 C0183479 C0449788 C1561528 C1709707 C4760793,,,,COVID-19,C5203670,,,COVID-19,C5203670,,
15,coronavirus outside body,long coronavirus live outside body,seek range information sars-cov-2's virus's survival different environment surface liquid etc outside human body still viable transmission another human,covid-19,,Extrinsic Genus: Coronavirus Body of stomach Human body Whole body Human body structure Body structure Document Body Adult human body,C0205101 C0206419 C0227230 C0242821 C0444584 C0460148 C1268086 C1551342 C4082212,Human body,C0242821,Extrinsic Genus: Coronavirus Human body,C0205101 C0206419 C0242821,Human body,C0242821,,Extrinsic Long Genus: Coronavirus Body of stomach Human body Lengthened (qualifier value) Whole body Human body structure Body structure Live - Specimen Condition Document Body Long Variable Reside Adult human body,C0205101 C0205166 C0206419 C0227230 C0242821 C0392744 C0444584 C0460148 C1268086 C1548795 C1551342 C1706317 C2982691 C4082212,Human body,C0242821,Extrinsic Genus: Coronavirus Human body Lengthened (qualifier value) Live - Specimen Condition,C0205101 C0206419 C0242821 C0392744 C1548795,Human body,C0242821,  Liquid dose form Liquid,Environment Continuance of life Virus Homo sapiens Extrinsic Surface survival aspects Liquid diet Liquid substance AS virus control act - information Liquid (finding) Range Information Error severity - Information Acknowledgement Detail Type - Information Liquid Dosage Form Different Sample Range Concept model range (foundation metadata concept) Liquid (state of matter) Liquid Dose Form Category Analytical Procedure Range SARS-CoV-2,C0014406 C0038952 C0042776 C0086418 C0205101 C0205148 C0220921 C0301571 C0302908 C0319157 C0870705 C1304698 C1514721 C1533716 C1561527 C1561528 C1697794 C1705242 C2348147 C3542016 C4521998 C4722465 C4760793 C5203676,Environment Homo sapiens,C0014406 C0086418,Environment Continuance of life Homo sapiens Extrinsic Surface AS virus Liquid (finding) Acknowledgement Detail Type - Information Different Analytical Procedure Range SARS-CoV-2,C0014406 C0038952 C0086418 C0205101 C0205148 C0319157 C1304698 C1561528 C1705242 C4760793 C5203676,Environment Homo sapiens,C0014406 C0086418,,COVID-19,C5203670,,,COVID-19,C5203670,,
16,long coronavirus survive surface,long coronavirus remain stable surface,study time sars-cov-2 remains stable deposit infected person everyday surface household hospital setting coughing touching object,covid-19,,Surface Long Genus: Coronavirus survive Lengthened (qualifier value) Long Variable,C0205148 C0205166 C0206419 C0310255 C0392744 C1706317,,,Surface Genus: Coronavirus survive Lengthened (qualifier value),C0205148 C0206419 C0310255 C0392744,,,,Surface Long Stable status Genus: Coronavirus Lengthened (qualifier value) Patient Condition Code - Stable Long Variable,C0205148 C0205166 C0205360 C0206419 C0392744 C1547311 C1706317,,,Surface Genus: Coronavirus Lengthened (qualifier value) Patient Condition Code - Stable,C0205148 C0206419 C0392744 C1547311,,,    Coughing Paroxysmal cough Haemoptysis  ,Coughing Hospitals Households Persons Time Studies Surface Stable status Daily Deposition Physical object Infected Tactile contextual factors Hospital environment Object Class Person Info Organization unit type - Hospital Patient Condition Code - Stable Parameterized Data Type - Set Computer Programming Object Person Observer Study start time Touching Application Context SARS-CoV-2,C0010200 C0019994 C0020052 C0027361 C0040227 C0205148 C0205360 C0332173 C0333562 C0347997 C0439663 C0439815 C0542559 C1510665 C1518526 C1522390 C1547192 C1547311 C1552652 C1704861 C2347489 C2349982 C2584295 C4281677 C5203676,Hospitals Households Time Studies,C0019994 C0020052 C0040227,Coughing Hospitals Households Time Studies Surface Daily Deposition Infected Tactile Person Info Patient Condition Code - Stable Computer Programming Object Application Context SARS-CoV-2,C0010200 C0019994 C0020052 C0040227 C0205148 C0332173 C0333562 C0439663 C0439815 C1522390 C1547311 C1704861 C4281677 C5203676,Hospitals Households Time Studies,C0019994 C0020052 C0040227,,COVID-19,C5203670,,,COVID-19,C5203670,,
17,coronavirus clinical trial,clinical trial available coronavirus,seek specific covid-19 clinical trial range trial recruitment complete trial result,covid-19,,Clinical Trials Genus: Coronavirus Clinical Trial [Publication Type] observation - clinical trial,C0008976 C0206419 C1096775 C1552009,,,Genus: Coronavirus Clinical Trial [Publication Type],C0206419 C1096775,,,,Clinical Trials Genus: Coronavirus Availability of Clinical Trial [Publication Type] observation - clinical trial,C0008976 C0206419 C0470187 C1096775 C1552009,,,Genus: Coronavirus Availability of Clinical Trial [Publication Type],C0206419 C0470187 C1096775,,,  Recruitment Loudness recruitment,Clinical Trials Complete Specific qualifier value Auditory recruitment Clinical Trial [Publication Type] Result Range What subject filter - Result Completion Status for valid values - Complete observation - clinical trial Entity Determiner - specific Finish - dosing instruction imperative Sample Range Experimental Result Recruitment Concept model range (foundation metadata concept) Data operation - complete Complete Pharyngeal Contraction Analytical Procedure Range COVID-19,C0008976 C0205197 C0205369 C0271510 C1096775 C1274040 C1514721 C1546471 C1548561 C1552009 C1552740 C1706059 C2348147 C2825142 C2949735 C3542016 C3853530 C4283785 C4760793 C5203670,,,Clinical Trials Complete Auditory recruitment Entity Determiner - specific Experimental Result Analytical Procedure Range COVID-19,C0008976 C0205197 C0271510 C1552740 C2825142 C4760793 C5203670,,,,COVID-19,C5203670,,,COVID-19,C5203670,,
18,mask prevent coronavirus,best mask prevent infection covid-19,type mask use prevent infection covid-19,covid-19,,Masks Genus: Coronavirus PREVENT (product) ANKHD1 gene masked - No information STK26 gene,C0024861 C0206419 C0309872 C1538279 C1555580 C1845191,Masks,C0024861,Masks Genus: Coronavirus PREVENT (product),C0024861 C0206419 C0309872,Masks,C0024861,,Communicable Diseases Masks PREVENT (product) best (quality) ANKHD1 gene masked - No information Adverse Event Associated with Infection BEST1 gene STK26 gene Infection COVID-19,C0009450 C0024861 C0309872 C1522427 C1538279 C1555580 C1556682 C1826421 C1845191 C3714514 C5203670,Communicable Diseases Masks,C0009450 C0024861,Communicable Diseases Masks PREVENT (product) BEST1 gene COVID-19,C0009450 C0024861 C0309872 C1826421 C5203670,Communicable Diseases Masks,C0009450 C0024861,,Communicable Diseases Masks utilization qualifier PREVENT (product) Type - attribute Usage SGCG gene ANKHD1 gene Type - ParameterizedDataType masked - No information Adverse Event Associated with Infection STK26 gene Use - dosing instruction imperative Infection GDC Type Terminology COVID-19,C0009450 C0024861 C0042153 C0309872 C0332307 C0457083 C1420009 C1538279 C1552651 C1555580 C1556682 C1845191 C1947944 C3714514 C5202910 C5203670,Communicable Diseases Masks,C0009450 C0024861,Communicable Diseases Masks PREVENT (product) Usage GDC Type Terminology COVID-19,C0009450 C0024861 C0309872 C0457083 C5202910 C5203670,Communicable Diseases Masks,C0009450 C0024861,,COVID-19,C5203670,,,COVID-19,C5203670,,
19,alcohol sanitizer kill coronavirus,type hand sanitizer need destroy covid-19,study assess chemical concentration need destroy covid-19 virus,covid-19, Alcohol ,ethanol Alcohols Killing sanitizers Ethanol measurement Genus: Coronavirus Sacrifice Alcohol - Recreational Drug Use Code kill - ActRelationshipJoin,C0001962 C0001975 C0162388 C0183086 C0202304 C0206419 C0681205 C1547288 C1550555,ethanol Killing,C0001962 C0162388,ethanol Killing sanitizers Genus: Coronavirus,C0001962 C0162388 C0183086 C0206419,ethanol Killing,C0001962 C0162388, ,Hand Needs sanitizers Type - attribute Sacrifice Patient need for (contextual qualifier) Entire hand SGCG gene Type - ParameterizedDataType hand - unit of measure Destruction (action) GDC Type Terminology COVID-19,C0018563 C0027552 C0183086 C0332307 C0681205 C0686904 C1281583 C1420009 C1552651 C1552914 C1948029 C5202910 C5203670,Hand Needs,C0018563 C0027552,Hand Needs sanitizers Destruction (action) GDC Type Terminology COVID-19,C0018563 C0027552 C0183086 C1948029 C5202910 C5203670,Hand Needs,C0018563 C0027552,   ,Clinical Research Needs Virus Mental concentration Chemicals AS virus Room of building - Study Sacrifice Patient need for (contextual qualifier) Scientific Study Chemical restraint (procedure) Concentration measurement Assessed Study Object DICOM Study Destruction (action) Study Chemical or Textual Reference to Actual Test or Parameter Able to Concentrate Question Chemical Challenge Agent COVID-19,C0008972 C0027552 C0042776 C0086045 C0220806 C0319157 C0557651 C0681205 C0686904 C0947630 C1320374 C1446561 C1516048 C1705923 C1880229 C1948029 C2603343 C3272558 C3827302 C4761398 C5203670,Needs,C0027552,Clinical Research Needs AS virus Assessed Destruction (action) Able to Concentrate Question Chemical Challenge Agent COVID-19,C0008972 C0027552 C0319157 C1516048 C1948029 C3827302 C4761398 C5203670,Needs,C0027552,,COVID-19,C5203670,,,COVID-19,C5203670,,
20,coronavirus ace inhibitor,patient take angiotensin-converting enzyme inhibitor ace increase risk covid-19,look information interaction coronavirus angiotensin convert enzyme ace2 receptor risk patient take medication recommendation patient,covid-19,,Angiotensin-Converting Enzyme Inhibitors Genus: Coronavirus angiotensin-converting enzyme inhibitor activity Angiotensin-converting enzyme inhibitor (disposition),C0003015 C0206419 C1152583 C4541021,Angiotensin-Converting Enzyme Inhibitors,C0003015,Angiotensin-Converting Enzyme Inhibitors Genus: Coronavirus,C0003015 C0206419,Angiotensin-Converting Enzyme Inhibitors,C0003015,,"Angiotensin-Converting Enzyme Inhibitors Patients Risk cyclophosphamide/doxorubicin protocol CDE protocol-cyclophosphamide/doxorubicin/etoposide Angiotensin converting enzyme measurement cisplatin/cytarabine/etoposide protocol Increase Achinese language ACE gene ACE protein, human Take Specimen Type - Patient Mail Claim Party - Patient Report source - Patient Relationship modifier - Patient Specimen Source Codes - Patient Disabled Person Code - Patient Veterinary Patient Adverse Childhood Experience Survey Angiotensin-converting enzyme inhibitor (disposition) Subject Risk COVID-19",C0003015 C0030705 C0035647 C0050385 C0108844 C0201888 C0279078 C0442805 C0574363 C1413931 C1452534 C1515187 C1550655 C1578481 C1578483 C1578484 C1578485 C1578486 C1705908 C4284014 C4541021 C4552904 C5203670,"Angiotensin-Converting Enzyme Inhibitors Risk ACE protein, human",C0003015 C0035647 C1452534,"Angiotensin-Converting Enzyme Inhibitors Patients Risk Increase ACE protein, human Take COVID-19",C0003015 C0030705 C0035647 C0442805 C1452534 C1515187 C5203670,"Angiotensin-Converting Enzyme Inhibitors Risk ACE protein, human",C0003015 C0035647 C1452534,  Enzyme Thymoglobulin Lymphocyte immunoglobulin ,"Angiotensins Enzymes Patients Risk Genus: Coronavirus Personal appearance receptor Drug Interactions control act - information ACE2 gene Information Event Qualification - Interaction Specimen Type - Patient Error severity - Information Acknowledgement Detail Type - Information Mail Claim Party - Patient Report source - Patient Relationship modifier - Patient Specimen Source Codes - Patient Disabled Person Code - Patient Interaction Veterinary Patient Angiotensin-1, human Enzyme (disposition) Subject Risk",C0003018 C0014442 C0030705 C0035647 C0206419 C0233426 C0597357 C0687133 C0870705 C1422064 C1533716 C1546938 C1550655 C1561527 C1561528 C1578481 C1578483 C1578484 C1578485 C1578486 C1704675 C1705908 C4521302 C4521602 C4552904,Angiotensins Enzymes Risk Drug Interactions,C0003018 C0014442 C0035647 C0687133,Angiotensins Enzymes Patients Risk Genus: Coronavirus Personal appearance receptor Drug Interactions ACE2 gene Acknowledgement Detail Type - Information,C0003018 C0014442 C0030705 C0035647 C0206419 C0233426 C0597357 C0687133 C1422064 C1561528,Angiotensins Enzymes Risk Drug Interactions,C0003018 C0014442 C0035647 C0687133,,COVID-19,C5203670,,,COVID-19,C5203670,,
21,coronavirus mortality,mortality rate overall specific population,seek information covid-19 fatality rate different country different population group base gender blood type factor,covid-19,,Mortality Vital Statistics Aspects of mortality statistics Genus: Coronavirus,C0026565 C0026566 C0206419,,,Aspects of mortality statistics Genus: Coronavirus,C0026566 C0206419,,,,Mortality Vital Statistics Death Rate Overall Publication Type Overall Specific population,C0026565 C0205848 C0282416 C1561607 C4740649,Death Rate Overall,C0205848 C1561607,Death Rate Overall Specific population,C0205848 C1561607 C4740649,Death Rate Overall,C0205848 C1561607,    Alkali ,Alkalies Blood Group (classification) Gender Base Structure of base of prostate Country control act - information Rating (action) Population Group Blood Types Country Code Factor Rate sex Information Amount type - Rate Base - RX Component Type base - RoleClass AddressPartType - country Error severity - Information Acknowledgement Detail Type - Information Jurisdictional Breadth - Country Unit dose - Base nitrogenous base Different Base - General Qualifier BPIFA4P gene CDISC SDTM Country Terminology Dental Base Mathematical Factor Encounter due to blood type Anatomical base COVID-19,C0002055 C0005810 C0079399 C0178499 C0227958 C0454664 C0870705 C0871208 C1257890 C1383165 C1511538 C1521761 C1521828 C1522384 C1533716 C1549480 C1549548 C1550601 C1550710 C1561527 C1561528 C1610174 C1626935 C1704464 C1705242 C1705938 C1843354 C1879931 C1880279 C2827422 C2911644 C2987514 C5203670,Gender Population Group sex,C0079399 C1257890 C1522384,Alkalies Blood Group (classification) Gender Population Group Factor Amount type - Rate AddressPartType - country Acknowledgement Detail Type - Information Different COVID-19,C0002055 C0005810 C0079399 C1257890 C1521761 C1549480 C1550710 C1561528 C1705242 C5203670,Gender Population Group,C0079399 C1257890,,COVID-19,C5203670,,,COVID-19,C5203670,,
22,coronavirus heart impact,cardiac complication likely patient covid-19,seek information type frequency mechanism cardiac complication cause coronavirus,covid-19,,Heart Genus: Coronavirus Entire heart IMPACT gene Impact,C0018787 C0206419 C1281570 C1825598 C4049986,,,Heart Genus: Coronavirus IMPACT gene,C0018787 C0206419 C1825598,,,,Patients Cardiac complication Probable diagnosis Probably Specimen Type - Patient Mail Claim Party - Patient Report source - Patient Relationship modifier - Patient Specimen Source Codes - Patient Disabled Person Code - Patient Veterinary Patient COVID-19,C0030705 C0161816 C0332148 C0750492 C1550655 C1578481 C1578483 C1578484 C1578485 C1578486 C1705908 C5203670,,,Patients Cardiac complication Probable diagnosis COVID-19,C0030705 C0161816 C0332148 C5203670,,,,Etiology aspects Cardiac complication Genus: Coronavirus Type - attribute With frequency Frequencies (time pattern) Mechanism (attribute) control act - information Spatial Frequency SGCG gene Science of Etiology Information Type - ParameterizedDataType Error severity - Information Acknowledgement Detail Type - Information Kind of quantity - Frequency Statistical Frequency Mechanism Component of Device CDISC SDTM Frequency Terminology Signal Frequency How Often Frequency GDC Type Terminology,C0015127 C0161816 C0206419 C0332307 C0376249 C0439603 C0441712 C0870705 C0871396 C1420009 C1524003 C1533716 C1552651 C1561527 C1561528 C1561548 C1705502 C1706376 C2347273 C3828023 C3898838 C4321352 C5202910,Frequency,C4321352,Etiology aspects Cardiac complication Genus: Coronavirus Mechanism (attribute) Acknowledgement Detail Type - Information Frequency GDC Type Terminology,C0015127 C0161816 C0206419 C0441712 C1561528 C4321352 C5202910,Frequency,C4321352,,COVID-19,C5203670,,,COVID-19,C5203670,,
23,coronavirus hypertension,kinds complication relate covid-19 associate hypertension,seek specific outcome hypertensive type patient less likely face infect virus,covid-19,,"Hypertensive disease Genus: Coronavirus Hypertension, CTCAE",C0020538 C0206419 C1963138,,,"Genus: Coronavirus Hypertension, CTCAE",C0206419 C1963138,,,,"Complication Hypertensive disease Relate - vinyl resin Associate - relationship Associate - assistant Hypertension, CTCAE Complication (attribute) COVID-19",C0009566 C0020538 C0163712 C0750490 C1706221 C1963138 C2362589 C5203670,,,"Complication Relate - vinyl resin Associate - assistant Hypertension, CTCAE COVID-19",C0009566 C0163712 C1706221 C1963138 C5203670,,,  Facial Afro-Caribbean childhood eruption   ,"Face Patients Virus Specific qualifier value AS virus Probable diagnosis Type - attribute Less Than Infected Smaller Probably Hypertensive (finding) Result Entire face SGCG gene ELOVL6 gene Specimen Type - Patient Type - ParameterizedDataType Entity Determiner - specific Mail Claim Party - Patient Report source - Patient Relationship modifier - Patient Specimen Source Codes - Patient Disabled Person Code - Patient Veterinary Patient FANCE wt Allele FANCONI ANEMIA, COMPLEMENTATION GROUP E Infection Face (spatial concept) GDC Type Terminology",C0015450 C0030705 C0042776 C0205369 C0319157 C0332148 C0332307 C0439092 C0439663 C0547044 C0750492 C0857121 C1274040 C1281591 C1420009 C1423759 C1550655 C1552651 C1552740 C1578481 C1578483 C1578484 C1578485 C1578486 C1705908 C2828055 C3160739 C3714514 C4284034 C5202910,Face,C0015450,Face Patients AS virus Probable diagnosis Less Than Infected Hypertensive (finding) Result Entity Determiner - specific GDC Type Terminology,C0015450 C0030705 C0319157 C0332148 C0439092 C0439663 C0857121 C1274040 C1552740 C5202910,Face,C0015450,,COVID-19,C5203670,,,COVID-19,C5203670,,
24,coronavirus diabetes,kinds complication relate covid-19 associate diabetes,seek specific outcome diabetic type patient less likely face infect virus,covid-19,,Diabetes Diabetes Mellitus Genus: Coronavirus,C0011847 C0011849 C0206419,Diabetes Mellitus,C0011849,Diabetes Mellitus Genus: Coronavirus,C0011849 C0206419,Diabetes Mellitus,C0011849,,Complication Diabetes Diabetes Mellitus Relate - vinyl resin Associate - relationship Associate - assistant Complication (attribute) COVID-19,C0009566 C0011847 C0011849 C0163712 C0750490 C1706221 C2362589 C5203670,Diabetes Mellitus,C0011849,Complication Diabetes Mellitus Relate - vinyl resin Associate - assistant COVID-19,C0009566 C0011849 C0163712 C1706221 C5203670,Diabetes Mellitus,C0011849,  Facial Afro-Caribbean childhood eruption   ,"Face Patients Virus Specific qualifier value diabetic AS virus Probable diagnosis Type - attribute Less Than Infected Smaller Probably Result Entire face SGCG gene ELOVL6 gene Specimen Type - Patient Type - ParameterizedDataType Entity Determiner - specific Mail Claim Party - Patient Report source - Patient Relationship modifier - Patient Specimen Source Codes - Patient Disabled Person Code - Patient Veterinary Patient FANCE wt Allele FANCONI ANEMIA, COMPLEMENTATION GROUP E Infection Face (spatial concept) GDC Type Terminology",C0015450 C0030705 C0042776 C0205369 C0241863 C0319157 C0332148 C0332307 C0439092 C0439663 C0547044 C0750492 C1274040 C1281591 C1420009 C1423759 C1550655 C1552651 C1552740 C1578481 C1578483 C1578484 C1578485 C1578486 C1705908 C2828055 C3160739 C3714514 C4284034 C5202910,Face,C0015450,Face Patients diabetic AS virus Probable diagnosis Less Than Infected Result Entity Determiner - specific GDC Type Terminology,C0015450 C0030705 C0241863 C0319157 C0332148 C0439092 C0439663 C1274040 C1552740 C5202910,Face,C0015450,,COVID-19,C5203670,,,COVID-19,C5203670,,
25,coronavirus biomarkers,biomarkers predict severe clinical course 2019-ncov infection,look information biomarkers predict disease outcome people infect coronavirus specifically predict severe fatal outcome,covid-19,,Biological Markers Genus: Coronavirus,C0005516 C0206419,,,Biological Markers Genus: Coronavirus,C0005516 C0206419,,,,Biological Markers Communicable Diseases Adverse Event Associated with Infection Severe clinical course Infection SARS-CoV-2,C0005516 C0009450 C1556682 C1832406 C3714514 C5203676,Communicable Diseases,C0009450,Biological Markers Communicable Diseases Severe clinical course SARS-CoV-2,C0005516 C0009450 C1832406 C5203676,Communicable Diseases,C0009450,,Biological Markers Personal appearance Disease Outcome control act - information Information Error severity - Information Acknowledgement Detail Type - Information CDISC SDTM Disease Outcome Terminology,C0005516 C0233426 C0679250 C0870705 C1533716 C1561527 C1561528 C3542417,,,Biological Markers Personal appearance Acknowledgement Detail Type - Information CDISC SDTM Disease Outcome Terminology,C0005516 C0233426 C1561528 C3542417,,,,COVID-19,C5203670,,,COVID-19,C5203670,,
26,coronavirus early symptom,initial symptom covid-19,study patient first clinical manifestation develop upon active infection,covid-19,,Genus: Coronavirus Early Symptoms Symptom:Find:Pt:^Patient:Nom,C0206419 C1279919 C1457887 C3854129,Symptoms,C1457887,Genus: Coronavirus Early Symptoms,C0206419 C1279919 C1457887,Symptoms,C1457887,,Initially Firstly Symptoms Initial (abbreviation) Initial Adverse Event and Product Problem Report Initial Usage Symptom:Find:Pt:^Patient:Nom COVID-19,C0205265 C1279901 C1457887 C1555582 C1705684 C1705685 C3854129 C5203670,Symptoms,C1457887,Firstly Symptoms COVID-19,C1279901 C1457887 C5203670,Symptoms,C1457887,,Clinical Research Communicable Diseases Patients Active Clinical Manifest First (number) Room of building - Study Active State Active brand of pseudoephedrine-triprolidine Scientific Study Firstly Manifestation of Specimen Type - Patient Concept Status - Active Adverse Event Associated with Infection EditStatus - Active Managed Participation Status - active Role Status - active Entity Status - active Document Storage - active Document Storage Status - Active Immunization Registry Status - Active Mail Claim Party - Patient Report source - Patient Relationship modifier - Patient Specimen Source Codes - Patient Disabled Person Code - Patient Veterinary Patient Study Object Active Control Upon - dosing instruction fragment DICOM Study Active Study Study Clinical Lot Infection active (HL7 RoleLink) Active License Clinical Batch,C0008972 C0009450 C0030705 C0205177 C0205210 C0205319 C0205435 C0557651 C0679217 C0718247 C0947630 C1279901 C1280464 C1550655 C1553875 C1556682 C1561507 C1561508 C1561509 C1561510 C1561511 C1561512 C1561513 C1578481 C1578483 C1578484 C1578485 C1578486 C1705908 C1705923 C1706449 C1720176 C1880229 C2347179 C2603343 C3272565 C3714514 C3853793 C3888249 C4523057,Communicable Diseases,C0009450,Clinical Research Communicable Diseases Patients Active Clinical Manifest First (number) Upon - dosing instruction fragment,C0008972 C0009450 C0030705 C0205177 C0205210 C0205319 C0205435 C1720176,Communicable Diseases,C0009450,,COVID-19,C5203670,,,COVID-19,C5203670,,
27,coronavirus asymptomatic,know infected covid-19 asymptomatic,study people know infect covid-19 show symptom,covid-19, Asymptomatic,Genus: Coronavirus Asymptomatic,C0206419 C0231221,,,Genus: Coronavirus Asymptomatic,C0206419 C0231221,,, Asymptomatic,Asymptomatic Infected COVID-19,C0231221 C0439663 C5203670,,,Asymptomatic Infected COVID-19,C0231221 C0439663 C5203670,,,,Clinical Research Persons Infected Room of building - Study Scientific Study Symptoms Show Study Object DICOM Study Study Infection Symptom:Find:Pt:^Patient:Nom COVID-19,C0008972 C0027361 C0439663 C0557651 C0947630 C1457887 C1547282 C1705923 C1880229 C2603343 C3714514 C3854129 C5203670,Symptoms,C1457887,Clinical Research Persons Infected Symptoms Show COVID-19,C0008972 C0027361 C0439663 C1457887 C1547282 C5203670,Symptoms,C1457887,,COVID-19,C5203670,,,COVID-19,C5203670,,
28,coronavirus hydroxychloroquine,evidence value hydroxychloroquine treat covid-19,basic science clinical study assess benefit harm treat covid-19 hydroxychloroquine,covid-19, Hydroxychloroquine,hydroxychloroquine Genus: Coronavirus,C0020336 C0206419,hydroxychloroquine,C0020336,hydroxychloroquine Genus: Coronavirus,C0020336 C0206419,hydroxychloroquine,C0020336, Hydroxychloroquine,hydroxychloroquine Therapeutic procedure Treatment intent Treating Numerical value MDF Attribute Type - Value Evidence COVID-19,C0020336 C0087111 C1292734 C1522326 C1522609 C1554112 C3887511 C5203670,hydroxychloroquine,C0020336,hydroxychloroquine Therapeutic procedure MDF Attribute Type - Value Evidence COVID-19,C0020336 C0087111 C1554112 C3887511 C5203670,hydroxychloroquine,C0020336,  Hydroxychloroquine,Clinical Research hydroxychloroquine Therapeutic procedure Basic Research Benefit Treatment intent Assessed Treating COVID-19,C0008972 C0020336 C0087111 C0681833 C0814225 C1292734 C1516048 C1522326 C5203670,hydroxychloroquine,C0020336,Clinical Research hydroxychloroquine Therapeutic procedure Basic Research Benefit Assessed COVID-19,C0008972 C0020336 C0087111 C0681833 C0814225 C1516048 C5203670,hydroxychloroquine,C0020336,,COVID-19,C5203670,,,COVID-19,C5203670,,
29,coronavirus drug repurposing,sars-cov-2 proteins-human protein interaction indicate potential drug target approve drug repurposed base information,seek information protein-protein interaction sars-cov-2 structural protein represent promising therapeutic target drug molecule may inhibit virus host cell receptor entry step,covid-19,,Genus: Coronavirus Drug Repositioning,C0206419 C2936405,Drug Repositioning,C2936405,Genus: Coronavirus Drug Repositioning,C0206419 C2936405,Drug Repositioning,C2936405,      Alkali,"Alkalies Pharmaceutical Preparations Proteins Drug Delivery Systems Base Approved Structure of base of prostate control act - information Protein-Protein Interaction NR4A2 protein, human Pharmacologic Substance Information Base - RX Component Type base - RoleClass Error severity - Information Acknowledgement Detail Type - Information Unit dose - Base nitrogenous base Base - General Qualifier BPIFA4P gene Dental Base Anatomical base Potential SARS-CoV-2",C0002055 C0013227 C0033684 C0085104 C0178499 C0205540 C0227958 C0870705 C0872079 C1142652 C1254351 C1533716 C1549548 C1550601 C1561527 C1561528 C1626935 C1704464 C1705938 C1843354 C1880279 C2987514 C3245505 C5203676,"Drug Delivery Systems NR4A2 protein, human",C0085104 C1142652,"Alkalies Pharmaceutical Preparations Proteins Drug Delivery Systems Approved Protein-Protein Interaction NR4A2 protein, human Acknowledgement Detail Type - Information Potential SARS-CoV-2",C0002055 C0013227 C0033684 C0085104 C0205540 C0872079 C1142652 C1561528 C3245505 C5203676,"Drug Delivery Systems NR4A2 protein, human",C0085104 C1142652,        ,Drug Delivery Systems Therapeutic procedure Therapeutic Molecule Structural protein receptor virus by host Therapeutic brand of coal tar control act - information Protein-Protein Interaction Step (specific stage) PTPN5 gene Information Therapeutic - Location Service Code entry - ActRelationshipCheckpoint entry - ActClass Error severity - Information Acknowledgement Detail Type - Information Treatment Step Increment Entry (data) Host Cell Representation (action) Stair (equipment) Month of May SARS-CoV-2,C0085104 C0087111 C0302350 C0567416 C0582263 C0597357 C0682447 C0723712 C0870705 C0872079 C1261552 C1419107 C1533716 C1547427 C1550548 C1555714 C1561527 C1561528 C1704379 C1705117 C1705654 C1819995 C1882932 C2825408 C3812381 C5203676,Drug Delivery Systems,C0085104,Drug Delivery Systems Therapeutic Molecule Structural protein receptor virus by host Protein-Protein Interaction Acknowledgement Detail Type - Information Increment Entry (data) Host Cell Representation (action) Month of May SARS-CoV-2,C0085104 C0302350 C0567416 C0582263 C0597357 C0682447 C0872079 C1561528 C1705117 C1705654 C1819995 C1882932 C3812381 C5203676,Drug Delivery Systems,C0085104,,COVID-19,C5203670,,,COVID-19,C5203670,,
30,coronavirus remdesivir,remdesivir effective treatment covid-19,seek specific information clinical outcome covid-19 patient treat remdesivir,covid-19,,Genus: Coronavirus remdesivir,C0206419 C4726677,remdesivir,C4726677,Genus: Coronavirus remdesivir,C0206419 C4726677,remdesivir,C4726677,,therapeutic aspects Therapeutic procedure Effectiveness Treating Administration procedure Effective Biomaterial Treatment Treatment Study Treatment Epoch treatment - ActInformationManagementReason remdesivir COVID-19,C0039798 C0087111 C1280519 C1522326 C1533734 C1704419 C1705169 C3161471 C3538994 C3887704 C4726677 C5203670,remdesivir,C4726677,Administration procedure Effective remdesivir COVID-19,C1533734 C1704419 C4726677 C5203670,remdesivir,C4726677,,Patients Therapeutic procedure Clinical Specific qualifier value control act - information Result Treatment intent Treating Information Specimen Type - Patient Entity Determiner - specific Error severity - Information Acknowledgement Detail Type - Information Mail Claim Party - Patient Report source - Patient Relationship modifier - Patient Specimen Source Codes - Patient Disabled Person Code - Patient Veterinary Patient Clinical Lot Clinical Batch remdesivir COVID-19,C0030705 C0087111 C0205210 C0205369 C0870705 C1274040 C1292734 C1522326 C1533716 C1550655 C1552740 C1561527 C1561528 C1578481 C1578483 C1578484 C1578485 C1578486 C1705908 C3272565 C4523057 C4726677 C5203670,remdesivir,C4726677,Patients Therapeutic procedure Clinical Result Entity Determiner - specific Acknowledgement Detail Type - Information remdesivir COVID-19,C0030705 C0087111 C0205210 C1274040 C1552740 C1561528 C4726677 C5203670,remdesivir,C4726677,,COVID-19,C5203670,,,COVID-19,C5203670,,
31,difference coronavirus flu,coronavirus differ seasonal flu,include study range focus genomic difference global public health impact must draw direct comparison covid-19 seasonal influenza,covid-19, Influenza Avian influenza Family Orthomyxoviridae,Influenza Genus: Coronavirus Delta (difference) Different Fluorescence Units ZMYND10 wt Allele,C0021400 C0206419 C1705241 C1705242 C2348686 C3811318,Influenza,C0021400,Influenza Genus: Coronavirus Delta (difference),C0021400 C0206419 C1705241,Influenza,C0021400,  Influenza Avian influenza Family Orthomyxoviridae,Influenza Genus: Coronavirus Seasonal course Fluorescence Units ZMYND10 wt Allele,C0021400 C0206419 C0439601 C2348686 C3811318,Influenza,C0021400,Influenza Genus: Coronavirus Seasonal course,C0021400 C0206419 C0439601,Influenza,C0021400,  Influenza Avian influenza Family Orthomyxoviridae,Clinical Research Drawings (art) Genome Influenza Influenza virus vaccine public health medicine (field) Focal Generalized Including (qualifier) Seasonal course Direct type of relationship Room of building - Study Public health service Genomics Scientific Study Has focus Range Direct - PostalAddressUse include - SetOperator Delta (difference) Different Study Object Comparison IMPACT gene DICOM Study Direct (qualifier) Sample Range Global Study Include (action) Private Communication Address Public health domain Concept model range (foundation metadata concept) Impact Analytical Procedure Range COVID-19,C0008972 C0013113 C0017428 C0021400 C0021403 C0034019 C0205234 C0205246 C0332257 C0439601 C0439851 C0557651 C0699943 C0887950 C0947630 C1285542 C1514721 C1552596 C1552866 C1705241 C1705242 C1705923 C1707455 C1825598 C1880229 C1947931 C2348147 C2348867 C2603343 C2700399 C3244286 C3244304 C3542016 C4049986 C4760793 C5203670,Genome Influenza Influenza virus vaccine Public health service Genomics,C0017428 C0021400 C0021403 C0699943 C0887950,Clinical Research Drawings (art) Influenza Focal Generalized Seasonal course Public health service Genomics Delta (difference) Comparison IMPACT gene Direct (qualifier) Include (action) Analytical Procedure Range COVID-19,C0008972 C0013113 C0021400 C0205234 C0205246 C0439601 C0699943 C0887950 C1705241 C1707455 C1825598 C1947931 C2700399 C4760793 C5203670,Influenza Public health service Genomics,C0021400 C0699943 C0887950,,COVID-19,C5203670,,,COVID-19,C5203670,,
32,coronavirus subtypes,sars-cov-2 subtypes,paper discuss subtypes virus name subtypes speculative subtypes base genomic geographic clustering,covid-19,,Genus: Coronavirus Subtype (attribute),C0206419 C0449560,,,Genus: Coronavirus Subtype (attribute),C0206419 C0449560,,,,Subtype (attribute) SARS-CoV-2,C0449560 C5203676,,,Subtype (attribute) SARS-CoV-2,C0449560 C5203676,,,   Alkali,Alkalies statistical cluster Genome Name Paper Virus Base Structure of base of prostate AS virus Subtype (attribute) Genomics Dioscorea trifida Geographic Person Name Paper Authorization Base - RX Component Type base - RoleClass MDF Attribute Type - Name Unit dose - Base nitrogenous base Base - General Qualifier BPIFA4P gene Dental Base Discussion (communication) Name:Patient number:Point in time:^Patient:Nominal Paper Dosing Unit Anatomical base Name (property) (qualifier value),C0002055 C0009085 C0017428 C0027365 C0030351 C0042776 C0178499 C0227958 C0319157 C0449560 C0887950 C1018834 C1517526 C1547383 C1547566 C1549548 C1550601 C1554107 C1626935 C1704464 C1705938 C1843354 C1880279 C2584313 C2599456 C2826224 C2987514 C4522128,Genome Name Paper Genomics,C0017428 C0027365 C0030351 C0887950,Alkalies statistical cluster Name Paper AS virus Subtype (attribute) Genomics Geographic Discussion (communication),C0002055 C0009085 C0027365 C0030351 C0319157 C0449560 C0887950 C1517526 C2584313,Name Paper Genomics,C0027365 C0030351 C0887950,,COVID-19,C5203670,,,COVID-19,C5203670,,
33,coronavirus vaccine candidate,vaccine candidate test covid-19,seek study discuss possible specific covid-19 vaccine include article describe mechanism action specific propose vaccine actual clinical trial exclude article name specific vaccine candidate,covid-19,,Vaccines Genus: Coronavirus Candidate,C0042210 C0206419 C4527371,Vaccines,C0042210,Vaccines Genus: Coronavirus Candidate,C0042210 C0206419 C4527371,Vaccines,C0042210,  ,Laboratory Procedures Testing Vaccines Tests (qualifier value) Test Result Test Dosing Unit Test Name Blood Products Laboratory Testing Test - temporal region Candidate COVID-19,C0022885 C0039593 C0042210 C0392366 C0456984 C1704435 C2826273 C3831328 C4318744 C4527371 C5203670,Vaccines,C0042210,Vaccines Blood Products Laboratory Testing Candidate COVID-19,C0042210 C3831328 C4527371 C5203670,Vaccines,C0042210,   ,Clinical Research Clinical Trials Name Vaccines Specific qualifier value Actual Possible Exclude Including (qualifier) Clinical action Mechanism (attribute) Room of building - Study Scientific Study Dioscorea trifida Clinical Trial [Publication Type] Person Name control act - action observation - clinical trial Entity Determiner - specific include - SetOperator Set Operator - exclude MDF Attribute Type - Name Possibly Related to Intervention Study Object Mechanism Component of Device Article DICOM Study Possible diagnosis Discussion (communication) Name:Patient number:Point in time:^Patient:Nominal Study Include (action) Exclusion Action Name (property) (qualifier value) Candidate Regulatory Action COVID-19,C0008972 C0008976 C0027365 C0042210 C0205369 C0237400 C0332149 C0332196 C0332257 C0441472 C0441712 C0557651 C0947630 C1018834 C1096775 C1547383 C1552007 C1552009 C1552740 C1552866 C1552867 C1554107 C1705910 C1705923 C1706376 C1706852 C1880229 C2362652 C2584313 C2599456 C2603343 C2700399 C2828389 C3266814 C4522128 C4527371 C5202992 C5203670,Name Vaccines,C0027365 C0042210,Clinical Research Name Vaccines Actual Possible Exclude Mechanism (attribute) Clinical Trial [Publication Type] Entity Determiner - specific Article Discussion (communication) Include (action) Action Candidate COVID-19,C0008972 C0027365 C0042210 C0237400 C0332149 C0332196 C0441712 C1096775 C1552740 C1706852 C2584313 C2700399 C3266814 C4527371 C5203670,Name Vaccines,C0027365 C0042210,,COVID-19,C5203670,,,COVID-19,C5203670,,
34,coronavirus recovery,longer-term complication recover covid-19,seek information health outcome recover virus exclude study focus adverse effect relate particular covid-19 drug,covid-19,,Genus: Coronavirus Recovery - action recovery - adjustment Recovery - healing process,C0206419 C0237820 C1555688 C2004454,,,Genus: Coronavirus Recovery - action,C0206419 C0237820,,,,"Complication Term Birth Recovering from Term (temporal) Term (lexical) Recovery - healing process Complication (attribute) Reported Term Human Cells, Tissues, and Cellular and Tissue-Based Products Recovery COVID-19",C0009566 C0233324 C0521108 C1515273 C1705313 C2004454 C2362589 C2826302 C3858677 C5203670,Term Birth,C0233324,"Complication Term Birth Human Cells, Tissues, and Cellular and Tissue-Based Products Recovery COVID-19",C0009566 C0233324 C3858677 C5203670,Term Birth,C0233324, ,"Clinical Research Pharmaceutical Preparations Health Virus Relate - vinyl resin Focal AS virus Exclude Recovering from Room of building - Study Adverse reactions control act - information Adverse effects Scientific Study Pharmacologic Substance Result Has focus Information Set Operator - exclude Error severity - Information Acknowledgement Detail Type - Information Study Object DICOM Study Recovery - healing process Study Exclusion Human Cells, Tissues, and Cellular and Tissue-Based Products Recovery COVID-19",C0008972 C0013227 C0018684 C0042776 C0163712 C0205234 C0319157 C0332196 C0521108 C0557651 C0559546 C0870705 C0879626 C0947630 C1254351 C1274040 C1285542 C1533716 C1552867 C1561527 C1561528 C1705923 C1880229 C2004454 C2603343 C2828389 C3858677 C5203670,Adverse effects,C0879626,"Clinical Research Pharmaceutical Preparations Health Relate - vinyl resin Focal AS virus Exclude Adverse effects Result Acknowledgement Detail Type - Information Human Cells, Tissues, and Cellular and Tissue-Based Products Recovery COVID-19",C0008972 C0013227 C0018684 C0163712 C0205234 C0319157 C0332196 C0879626 C1274040 C1561528 C3858677 C5203670,Adverse effects,C0879626,,COVID-19,C5203670,,,COVID-19,C5203670,,
35,coronavirus public datasets,new public datasets available related covid-19,seek article specifically release new data relate sars-cov-2 covid-19 include genomic data patient data public health data etc article reference previously exist datasets relevant,covid-19,,Genus: Coronavirus public entity Postal Address Use - Public,C0206419 C0678367 C1552597,,,Genus: Coronavirus Postal Address Use - Public,C0206419 C1552597,,, ,Relate - vinyl resin New Relationships Related personal status Availability of public entity Postal Address Use - Public Role Link Type - related Act Status - new Query Status Code - new Definitely Related to Intervention New Lesion Identification Newar Language COVID-19,C0163712 C0205314 C0439849 C0445223 C0470187 C0678367 C1552597 C1552599 C1553390 C1578513 C1704787 C2986548 C4724144 C5203670,,,Availability of Postal Address Use - Public Act Status - new Definitely Related to Intervention COVID-19,C0470187 C1552597 C1553390 C1704787 C5203670,,,  ,Genome Patient Discharge public health medicine (field) Relate - vinyl resin New Including (qualifier) Released (action) Discharge (release) Public health service Genomics Release - action (qualifier value) Data Bibliographic Reference include - SetOperator Act Status - new Reference - MdfHmdMetSourceType Query Status Code - new Reference Object Article Release (procedure) Relevance Include (action) Patient data New Lesion Identification Exist Public health domain Reference - HL7UpdateMode Data call receiving device Data (eukaryote) Release Determination Newar Language COVID-19 SARS-CoV-2,C0017428 C0030685 C0034019 C0163712 C0205314 C0332257 C0391871 C0680255 C0699943 C0887950 C1283071 C1511726 C1514811 C1552866 C1553390 C1561577 C1578513 C1706462 C1706852 C1963578 C2347946 C2700399 C2707520 C2986548 C2987476 C3244304 C3244318 C3245479 C3714741 C4521542 C4724144 C5203670 C5203676,Genome Patient Discharge Public health service Genomics,C0017428 C0030685 C0699943 C0887950,Patient Discharge Relate - vinyl resin Public health service Genomics Bibliographic Reference Act Status - new Article Relevance Include (action) Patient data Exist Data call receiving device COVID-19 SARS-CoV-2,C0030685 C0163712 C0699943 C0887950 C1514811 C1553390 C1706852 C2347946 C2700399 C2707520 C2987476 C3245479 C5203670 C5203676,Patient Discharge Public health service Genomics,C0030685 C0699943 C0887950,,COVID-19,C5203670,,,COVID-19,C5203670,,
36,sars-cov-2 spike structure,protein structure sars-cov-2 spike,look study structure spike protein virus use method cryo-em crystallography,covid-19,,Structure Spike SARS-CoV-2,C0678594 C3882441 C5203676,,,Structure Spike SARS-CoV-2,C0678594 C3882441 C5203676,,,  ,"Protein, Organized by Structure Protein Structure Spike SARS-CoV-2",C0175168 C1510464 C3882441 C5203676,,,"Protein, Organized by Structure Spike SARS-CoV-2",C0175168 C3882441 C5203676,,,     ,"Clinical Research Crystallography Methods utilization qualifier Viral Proteins Personal appearance Techniques Usage Room of building - Study Structure M Protein, multiple myeloma Test Method Scientific Study Study Object DICOM Study Use - dosing instruction imperative Study CDISC SDTM Method Terminology Method, LOINC Axis 6",C0008972 C0010424 C0025663 C0042153 C0042736 C0233426 C0449851 C0457083 C0557651 C0678594 C0700271 C0871511 C0947630 C1705923 C1880229 C1947944 C2603343 C2827714 C2828387,"Crystallography Methods Viral Proteins M Protein, multiple myeloma",C0010424 C0025663 C0042736 C0700271,"Clinical Research Crystallography Methods Viral Proteins Personal appearance Usage Structure M Protein, multiple myeloma",C0008972 C0010424 C0025663 C0042736 C0233426 C0457083 C0678594 C0700271,"Crystallography Methods Viral Proteins M Protein, multiple myeloma",C0010424 C0025663 C0042736 C0700271,,COVID-19,C5203670,,,COVID-19,C5203670,,
37,sars-cov-2 phylogenetic analysis,result phylogenetic analysis sars-cov-2 genome sequence,look range study provide result phylogenetic network analysis sars-cov-2 genome,covid-19,,Phylogenetic Analysis SARS-CoV-2,C1519068 C5203676,,,Phylogenetic Analysis SARS-CoV-2,C1519068 C5203676,,, ,Base Sequence Genome DNA Sequence RNA Sequence Result Phylogenetic Analysis Sequence What subject filter - Result Sequence - ParameterizedDataType Sequence - DataType Genome - anatomical entity Experimental Result Sequence - TransmissionRelationshipTypeCode SARS-CoV-2,C0004793 C0017428 C0162326 C0162327 C1274040 C1519068 C1519249 C1546471 C1547787 C1610719 C2338314 C2825142 C3853789 C5203676,Base Sequence Genome DNA Sequence RNA Sequence,C0004793 C0017428 C0162326 C0162327,Base Sequence Genome Phylogenetic Analysis Experimental Result SARS-CoV-2,C0004793 C0017428 C1519068 C2825142 C5203676,Base Sequence Genome,C0004793 C0017428, ,Clinical Research Genome Personal appearance Provide (product) Room of building - Study Pathway Analysis Scientific Study Result Range What subject filter - Result Study Object DICOM Study Providing (action) Genome - anatomical entity Sample Range Study Experimental Result Concept model range (foundation metadata concept) Analytical Procedure Range SARS-CoV-2,C0008972 C0017428 C0233426 C0359589 C0557651 C0868995 C0947630 C1274040 C1514721 C1546471 C1705923 C1880229 C1999230 C2338314 C2348147 C2603343 C2825142 C3542016 C4760793 C5203676,Genome,C0017428,Clinical Research Genome Personal appearance Provide (product) Pathway Analysis Experimental Result Analytical Procedure Range SARS-CoV-2,C0008972 C0017428 C0233426 C0359589 C0868995 C2825142 C4760793 C5203676,Genome,C0017428,,COVID-19,C5203670,,,COVID-19,C5203670,,
38,covid inflammatory response,mechanism inflammatory response pathogenesis covid-19 case,look range study describe inflammatory response cell pathogenesis coronavirus disease covid-19 outbreak include mechanism anti-inflammatory drug corticosteroid vitamin supplement,covid-19,,Inflammatory Response,C1155266,,,Inflammatory Response,C1155266,,,,Mechanism (attribute) pathogenic aspects Pathogenesis Case (situation) Inflammatory Response Case unit dose Packaging Case Clinical Study Case Mechanism Component of Device True Case Status COVID-19,C0441712 C0543483 C0699748 C0868928 C1155266 C1533148 C1706255 C1706256 C1706376 C3274647 C5203670,Pathogenesis,C0699748,Mechanism (attribute) Pathogenesis Case (situation) Inflammatory Response COVID-19,C0441712 C0699748 C0868928 C1155266 C5203670,Pathogenesis,C0699748,    ,Adrenal Cortex Hormones Anti-Inflammatory Agents Cells Clinical Research Disease Disease Outbreaks Pharmaceutical Preparations Genus: Coronavirus Personal appearance Including (qualifier) Mechanism (attribute) pathogenic aspects Room of building - Study Vitamin supplement Pathogenesis Scientific Study Cellular Phone Inflammatory Response Pharmacologic Substance Entire cell CEL gene Range Anti-inflammatory effect include - SetOperator Cell Device Study Object Mechanism Component of Device DICOM Study Cell (compartment) Sample Range Study Include (action) Corticosteroid [EPC] Concept model range (foundation metadata concept) Analytical Procedure Range COVID-19,C0001617 C0003209 C0007634 C0008972 C0012634 C0012652 C0013227 C0206419 C0233426 C0332257 C0441712 C0543483 C0557651 C0681579 C0699748 C0947630 C1136359 C1155266 C1254351 C1269647 C1413336 C1514721 C1515999 C1552866 C1704653 C1705923 C1706376 C1880229 C1948049 C2348147 C2603343 C2700399 C3536709 C3542016 C4760793 C5203670,Adrenal Cortex Hormones Anti-Inflammatory Agents Disease Disease Outbreaks Pathogenesis Cellular Phone,C0001617 C0003209 C0012634 C0012652 C0699748 C1136359,Adrenal Cortex Hormones Anti-Inflammatory Agents Clinical Research Disease Disease Outbreaks Pharmaceutical Preparations Genus: Coronavirus Personal appearance Mechanism (attribute) Vitamin supplement Pathogenesis Cellular Phone Inflammatory Response Include (action) Analytical Procedure Range COVID-19,C0001617 C0003209 C0008972 C0012634 C0012652 C0013227 C0206419 C0233426 C0441712 C0681579 C0699748 C1136359 C1155266 C2700399 C4760793 C5203670,Adrenal Cortex Hormones Anti-Inflammatory Agents Disease Disease Outbreaks Pathogenesis Cellular Phone,C0001617 C0003209 C0012634 C0012652 C0699748 C1136359,,COVID-19,C5203670,,,COVID-19,C5203670,,
39,covid-19 cytokine storm,mechanism cytokine storm syndrome covid-19,look study describe mechanism development cytokine storm syndrome among covid-19 case range drug use therapy cytokine storm,covid-19, Cytokine,cytokine COVID-19,C0079189 C5203670,,,cytokine COVID-19,C0079189 C5203670,,, Cytokine ,cytokine Mechanism (attribute) Mechanism Component of Device Storm Syndrome COVID-19,C0079189 C0441712 C1706376 C1861452 C5203670,Storm Syndrome,C1861452,cytokine Mechanism (attribute) Storm Syndrome COVID-19,C0079189 C0441712 C1861452 C5203670,Storm Syndrome,C1861452, Cytokine   ,Clinical Research cytokine Personal appearance development aspects Mechanism (attribute) Room of building - Study Biologic Development Scientific Study Development Study Object Mechanism Component of Device DICOM Study Study Development Lot Development Batch,C0008972 C0079189 C0233426 C0243107 C0441712 C0557651 C0678723 C0947630 C1527148 C1705923 C1706376 C1880229 C2603343 C3272564 C4521286,Development,C1527148,Clinical Research cytokine Personal appearance Mechanism (attribute) Development,C0008972 C0079189 C0233426 C0441712 C1527148,Development,C1527148,,COVID-19,C5203670,,,COVID-19,C5203670,,
40,coronavirus mutation,observed mutation sars-cov-2 genome often mutation occur,look study describe emergence genomic diversity coronavirus due recurrent mutation explore potential genomic site mutation mechanism potential observed clinical implication pathogenicity virus,covid-19,,Mutation Genus: Coronavirus Mutation Abnormality,C0026882 C0206419 C1705285,Mutation,C0026882,Mutation Genus: Coronavirus,C0026882 C0206419,Mutation,C0026882,    Frequent Infrequent Repeat ,Genome Mutation Frequently Observed Mutation Abnormality Occur (action) Genome - anatomical entity Occurrence Often - answer to question Occurrence Indicator SARS-CoV-2,C0017428 C0026882 C0332183 C1441672 C1705285 C1709305 C2338314 C2745955 C4050225 C4284875 C5203676,Genome Mutation Occurrence,C0017428 C0026882 C2745955,Genome Mutation Frequently Observed Occurrence SARS-CoV-2,C0017428 C0026882 C0332183 C1441672 C2745955 C5203676,Genome Mutation Occurrence,C0017428 C0026882 C2745955,  Recurrent    ,Clinical Research Genome Mutation Pathogenicity Aspects Virus Site Clinical Genus: Coronavirus Personal appearance AS virus Mechanism (attribute) Room of building - Study Due to Genomics Scientific Study Pathogenicity Observed Episodic Anatomic Site Specimen Source Codes - Site Mutation Abnormality Study Object Mechanism Component of Device DICOM Study Diversity Study Study Site Recurrent Due Potential Clinical Lot Clinical Batch,C0008972 C0017428 C0026882 C0030657 C0042776 C0205145 C0205210 C0206419 C0233426 C0319157 C0441712 C0557651 C0678226 C0887950 C0947630 C1136169 C1441672 C1455761 C1515974 C1546778 C1705285 C1705923 C1706376 C1880229 C1880371 C2603343 C2825164 C2945760 C3146286 C3245505 C3272565 C4523057,Genome Mutation Genomics Pathogenicity,C0017428 C0026882 C0887950 C1136169,Clinical Research Mutation Clinical Genus: Coronavirus Personal appearance AS virus Mechanism (attribute) Genomics Pathogenicity Observed Episodic Anatomic Site Diversity Due Potential,C0008972 C0026882 C0205210 C0206419 C0233426 C0319157 C0441712 C0887950 C1136169 C1441672 C1455761 C1515974 C1880371 C3146286 C3245505,Mutation Genomics Pathogenicity,C0026882 C0887950 C1136169,,COVID-19,C5203670,,,COVID-19,C5203670,,
41,covid-19 african-american,impact covid-19 among african-american differ rest u.s. population,look study analyze burden illness death among african-american black racial ethnic group include potential reason transmission morbidity mortality may include discussion minority group study contain specific information health disparity face african-american pandemic,covid-19,,African American COVID-19,C0085756 C5203670,,,African American COVID-19,C0085756 C5203670,,,,geographic population Rest African American Population Group REST gene site-specific telomere resolvase activity IMPACT gene Impact COVID-19,C0032659 C0035253 C0085756 C1257890 C1419346 C1622890 C1825598 C4049986 C5203670,Rest Population Group,C0035253 C1257890,Rest African American Population Group IMPACT gene COVID-19,C0035253 C0085756 C1257890 C1825598 C5203670,Rest Population Group,C0035253 C1257890,   Discussion  Facial Afro-Caribbean childhood eruption  ,"Black race Clinical Research Cessation of life Ethnic group Face Minority Groups Morbidity - disease rate Mortality Vital Statistics Aspects of mortality statistics African race disease transmission qualifier African American Cost of Illness Specific qualifier value morbidity aspects Personal appearance disease transmission Containing (qualifier) Including (qualifier) Indication of (contextual qualifier) Black color Discussion (procedure) Room of building - Study control act - information Scientific Study health disparity Entire face Death (finding) ELOVL6 gene transmission process Information Event Consequence - Death Entity Determiner - specific include - SetOperator Adverse Event Associated with Death Error severity - Information Acknowledgement Detail Type - Information Pandemics Black - Structured Product Labeling Color Study Object CDISC SDTM Patient Ethnic Group Terminology DICOM Study Discussion (communication) Study Include (action) Contain (action) FANCE wt Allele FANCONI ANEMIA, COMPLEMENTATION GROUP E Potential Month of May Face (spatial concept) Death Domain",C0005680 C0008972 C0011065 C0015031 C0015450 C0026192 C0026538 C0026565 C0026566 C0027567 C0040722 C0085756 C0162698 C0205369 C0220880 C0233426 C0242781 C0332256 C0332257 C0392360 C0439541 C0557061 C0557651 C0870705 C0947630 C1171307 C1281591 C1306577 C1423759 C1521797 C1533716 C1546949 C1552740 C1552866 C1559081 C1561527 C1561528 C1615608 C1704739 C1705923 C1879937 C1880229 C2584313 C2603343 C2700399 C2700400 C2828055 C3160739 C3245505 C3812381 C4284034 C4722467,Ethnic group Face Minority Groups Cost of Illness Pandemics Death Domain,C0015031 C0015450 C0026192 C0162698 C1615608 C4722467,Clinical Research Ethnic group Face Minority Groups Morbidity - disease rate Aspects of mortality statistics African American Cost of Illness Personal appearance disease transmission Indication of (contextual qualifier) health disparity Entity Determiner - specific Acknowledgement Detail Type - Information Pandemics Discussion (communication) Include (action) Contain (action) Potential Month of May Death Domain,C0008972 C0015031 C0015450 C0026192 C0026538 C0026566 C0085756 C0162698 C0233426 C0242781 C0392360 C1171307 C1552740 C1561528 C1615608 C2584313 C2700399 C2700400 C3245505 C3812381 C4722467,Ethnic group Face Minority Groups Cost of Illness Pandemics Death Domain,C0015031 C0015450 C0026192 C0162698 C1615608 C4722467,,COVID-19,C5203670,,,COVID-19,C5203670,,
42,vitamin covid-19,vitamin impact covid-19 prevention treatment,include study describe possible role vitamin prevention covid-19 suppression cytokine storm clinical outcome association vitamin status covid-19 mortality,covid-19, ,Vitamins COVID-19,C0042890 C5203670,Vitamins,C0042890,Vitamins COVID-19,C0042890 C5203670,Vitamins,C0042890, ,therapeutic aspects Vitamins Therapeutic procedure Prophylactic treatment Treating Administration procedure Biomaterial Treatment Prevention Study IMPACT gene prevention aspects Treatment Study Treatment Epoch treatment - ActInformationManagementReason Impact COVID-19,C0039798 C0042890 C0087111 C0199176 C1522326 C1533734 C1705169 C1706420 C1825598 C2700409 C3161471 C3538994 C3887704 C4049986 C5203670,Vitamins,C0042890,Vitamins Administration procedure Prevention Study IMPACT gene COVID-19,C0042890 C1533734 C1706420 C1825598 C5203670,Vitamins,C0042890,   Cytokine  ,Mental association Clinical Research Mortality Vital Statistics Aspects of mortality statistics Social Role Vitamins cytokine Prophylactic treatment Clinical Visual Suppression Metabolic Suppression Possible Including (qualifier) Relationships Status Room of building - Study Chemical Association Relationship by association Psychological suppression Scientific Study Result What subject filter - Status include - SetOperator role - RoleClass NCI Thesaurus Association Association Class Security Role Object Generic Role Terminology Role Entity NCI Thesaurus Role Possibly Related to Intervention Study Object Prevention Study DICOM Study Possible diagnosis Study Include (action) prevention aspects Clinical Lot Role Clinical Batch COVID-19,C0004083 C0008972 C0026565 C0026566 C0035820 C0042890 C0079189 C0199176 C0205210 C0221103 C0301625 C0332149 C0332257 C0439849 C0449438 C0557651 C0596306 C0699792 C0728721 C0947630 C1274040 C1546481 C1552866 C1704326 C1704770 C1704771 C1705809 C1705810 C1705811 C1705812 C1705910 C1705923 C1706420 C1880229 C2362652 C2603343 C2700399 C2700409 C3272565 C3871154 C4523057 C5203670,Vitamins Role,C0042890 C3871154,Clinical Research Aspects of mortality statistics Vitamins cytokine Clinical Metabolic Suppression Possible Status Result Association Class Prevention Study Include (action) Role COVID-19,C0008972 C0026566 C0042890 C0079189 C0205210 C0301625 C0332149 C0449438 C1274040 C1704771 C1706420 C2700399 C3871154 C5203670,Vitamins Role,C0042890 C3871154,,COVID-19,C5203670,,,COVID-19,C5203670,,
43,violence pandemic,covid-19 pandemic impact violence society include violent crime,look analysis data pandemic impact rate violence include domestic family violence relate quarantine,covid-19,,Violence Pandemics,C0042693 C1615608,Violence Pandemics,C0042693 C1615608,Violence Pandemics,C0042693 C1615608,Violence Pandemics,C0042693 C1615608,,Societies Violence Including (qualifier) violent crime include - SetOperator Pandemics IMPACT gene Include (action) Impact COVID-19,C0037455 C0042693 C0332257 C0680472 C1552866 C1615608 C1825598 C2700399 C4049986 C5203670,Societies Violence Pandemics,C0037455 C0042693 C1615608,Societies Violence violent crime Pandemics IMPACT gene Include (action) COVID-19,C0037455 C0042693 C0680472 C1615608 C1825598 C2700399 C5203670,Societies Violence Pandemics,C0037455 C0042693 C1615608,     Quarantine,"Analysis of substances Animals, Domestic Quarantine Violence Relate - vinyl resin Family Violence Personal appearance Including (qualifier) Home environment Rating (action) Analysis Data Rate analysis aspect Amount type - Rate include - SetOperator Pandemics IMPACT gene Domestic Include (action) Data call receiving device Data (eukaryote) Impact",C0002778 C0003063 C0034386 C0042693 C0163712 C0206072 C0233426 C0332257 C0442519 C0871208 C0936012 C1511726 C1521828 C1524024 C1549480 C1552866 C1615608 C1825598 C1880391 C2700399 C3245479 C3714741 C4049986,"Animals, Domestic Quarantine Violence Family Violence Pandemics",C0003063 C0034386 C0042693 C0206072 C1615608,"Animals, Domestic Quarantine Violence Relate - vinyl resin Family Violence Personal appearance Analysis Data Amount type - Rate Pandemics IMPACT gene Include (action)",C0003063 C0034386 C0042693 C0163712 C0206072 C0233426 C0936012 C1511726 C1549480 C1615608 C1825598 C2700399,"Animals, Domestic Quarantine Violence Family Violence Pandemics",C0003063 C0034386 C0042693 C0206072 C1615608,,COVID-19,C5203670,,,COVID-19,C5203670,,
44,impact mask coronavirus transmission,much impact mask prevent spread covid-19,look study masks slow sars-cov-2 transmission include impact r0 study include lab population study,covid-19,,Masks disease transmission qualifier Genus: Coronavirus disease transmission transmission process ANKHD1 gene masked - No information IMPACT gene STK26 gene Impact,C0024861 C0040722 C0206419 C0242781 C1521797 C1538279 C1555580 C1825598 C1845191 C4049986,Masks,C0024861,Masks Genus: Coronavirus disease transmission IMPACT gene,C0024861 C0206419 C0242781 C1825598,Masks,C0024861,,Masks PREVENT (product) Spreading (qualifier value) ANKHD1 gene masked - No information IMPACT gene STK26 gene Smear - instruction imperative Impact Much COVID-19,C0024861 C0309872 C0332261 C1538279 C1555580 C1825598 C1845191 C1947932 C4049986 C4281574 C5203670,Masks,C0024861,Masks PREVENT (product) IMPACT gene Smear - instruction imperative Much COVID-19,C0024861 C0309872 C1825598 C1947932 C4281574 C5203670,Masks,C0024861, ,Clinical Research Personal appearance Room of building - Study Scientific Study Study Object DICOM Study Study,C0008972 C0233426 C0557651 C0947630 C1705923 C1880229 C2603343,,,Clinical Research Personal appearance,C0008972 C0233426,,,,COVID-19,C5203670,,,COVID-19,C5203670,,
45,coronavirus mental health impact,covid-19 pandemic impact mental health,include increase decrease rate depression anxiety panic disorder psychiatric mental health condition,covid-19,,mental health Genus: Coronavirus IMPACT gene Impact,C0025353 C0206419 C1825598 C4049986,mental health,C0025353,mental health Genus: Coronavirus IMPACT gene,C0025353 C0206419 C1825598,mental health,C0025353,,mental health Pandemics IMPACT gene Impact COVID-19,C0025353 C1615608 C1825598 C4049986 C5203670,mental health Pandemics,C0025353 C1615608,mental health Pandemics IMPACT gene COVID-19,C0025353 C1615608 C1825598 C5203670,mental health Pandemics,C0025353 C1615608,    ,Mental disorders Disease mental health Panic Disorder Including (qualifier) Mixed anxiety and depressive disorder Condition Reduced Increase Decrease Rating (action) Rate Amount type - Rate include - SetOperator Logical Condition Include (action) Condition:Find:Pt:^Patient:Nom Condition Domain,C0004936 C0012634 C0025353 C0030319 C0332257 C0338908 C0348080 C0392756 C0442805 C0547047 C0871208 C1521828 C1549480 C1552866 C1705253 C2700399 C3864998 C4722256,Disease mental health Panic Disorder,C0012634 C0025353 C0030319,Mental disorders Disease mental health Panic Disorder Mixed anxiety and depressive disorder Increase Decrease Amount type - Rate Include (action),C0004936 C0012634 C0025353 C0030319 C0338908 C0442805 C0547047 C1549480 C2700399,Disease mental health Panic Disorder,C0012634 C0025353 C0030319,,COVID-19,C5203670,,,COVID-19,C5203670,,
